×
Pindolol Augmentation in Depressed Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Double-Blind, Randomized, Controlled Trial PDF
$ 40.00
Pindolol Augmentation in Depressed Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Double-Blind, Randomized, Controlled Trial PDF quantity
$ 40.00
×
Quetiapine for the Management of Tardive Dyskinesia in Schizoaffective Disorder Comorbid With Diabetes Mellitus and Chronic Kidney Disease PDF
$ 40.00
Quetiapine for the Management of Tardive Dyskinesia in Schizoaffective Disorder Comorbid With Diabetes Mellitus and Chronic Kidney Disease PDF quantity
$ 40.00
×
Association Between Personality Traits and Procrastination and the Mediating Effect of Emotional Intelligence in Lebanese Medical Students PDF
$ 40.00
Association Between Personality Traits and Procrastination and the Mediating Effect of Emotional Intelligence in Lebanese Medical Students PDF quantity
$ 40.00
×
A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder PDF
$ 40.00
A Long-Term Trial of the Effectiveness and Safety of Atypical Antipsychotic Agents in Augmenting SSRI-Refractory Obsessive-Compulsive Disorder PDF quantity
$ 40.00
×
Risperidone Long-Acting Therapy Prescribing Patterns and Their Impact on Early Discontinuation of Treatment in a Large Medicaid Population PDF
$ 40.00
Risperidone Long-Acting Therapy Prescribing Patterns and Their Impact on Early Discontinuation of Treatment in a Large Medicaid Population PDF quantity
$ 40.00
×
The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder PDF
$ 40.00
The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder PDF quantity
$ 40.00
×
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study PDF
$ 40.00
Remission With Venlafaxine Extended Release or Selective Serotonin Reuptake Inhibitors in Depressed Patients: A Randomized, Open-Label Study PDF quantity
$ 40.00
×
The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder PDF
$ 40.00
The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder PDF quantity
$ 40.00
×
Sociodemographic Characteristics and Cardiovascular Risk Factors in Patients With Severe Mental Disorders Compared With the General Population. PDF
$ 40.00
Sociodemographic Characteristics and Cardiovascular Risk Factors in Patients With Severe Mental Disorders Compared With the General Population. PDF quantity
$ 40.00
×
Psychiatric Diagnosis as an Independent Risk Factor for Metabolic Disturbances: Results From a Comprehensive, Naturalistic Screening Program PDF
$ 40.00
Psychiatric Diagnosis as an Independent Risk Factor for Metabolic Disturbances: Results From a Comprehensive, Naturalistic Screening Program PDF quantity
$ 40.00
×
Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III PDF
$ 40.00
Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III PDF quantity
$ 40.00
×
Speaking a More Consistent Language When Discussing Severe Depression: A Calibration Study of 3 Self-Report Measures of Depressive Symptoms PDF
$ 40.00
Speaking a More Consistent Language When Discussing Severe Depression: A Calibration Study of 3 Self-Report Measures of Depressive Symptoms PDF quantity
$ 40.00
×
Analysis of QT Dispersion, Corrected QT Dispersion, and P-Wave Dispersion Values in Alcohol Use Disorder Patients With Excessive Alcohol Use PDF
$ 40.00
Analysis of QT Dispersion, Corrected QT Dispersion, and P-Wave Dispersion Values in Alcohol Use Disorder Patients With Excessive Alcohol Use PDF quantity
$ 40.00
×
The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders PDF
$ 40.00
The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders PDF quantity
$ 40.00
×
The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF
$ 40.00
The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF quantity
$ 40.00
×
A Longitudinal Comparison Between Depressed Patients Receiving Electroconvulsive Therapy and Healthy Controls on Specific Memory Functions PDF
$ 40.00
A Longitudinal Comparison Between Depressed Patients Receiving Electroconvulsive Therapy and Healthy Controls on Specific Memory Functions PDF quantity
$ 40.00
×
Relationships Between Obsessive-Compulsive Symptomatology and Severity of Psychosis in Schizophrenia: A Systematic Review and Meta-Analysis PDF
$ 40.00
Relationships Between Obsessive-Compulsive Symptomatology and Severity of Psychosis in Schizophrenia: A Systematic Review and Meta-Analysis PDF quantity
$ 40.00
×
The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone PDF
$ 40.00
The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone PDF quantity
$ 40.00
×
Efficacy and Safety of Topiramate Monotherapy in Civilian Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Efficacy and Safety of Topiramate Monotherapy in Civilian Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
×
Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram PDF
$ 40.00
Which Factors Predict Placebo Response in Anxiety Disorders and Major Depression? An Analysis of Placebo-Controlled Studies of Escitalopram PDF quantity
$ 40.00
×
A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression PDF
$ 40.00
A Double-Blind Placebo-Controlled Trial of Lamotrigine as an Antidepressant Augmentation Agent in Treatment-Refractory Unipolar Depression PDF quantity
$ 40.00
×
Is Flunarizine a Long-Acting Oral Atypical Antipsychotic? A Randomized Clinical Trial Versus Haloperidol for the Treatment of Schizophrenia PDF
$ 40.00
Is Flunarizine a Long-Acting Oral Atypical Antipsychotic? A Randomized Clinical Trial Versus Haloperidol for the Treatment of Schizophrenia PDF quantity
$ 40.00
×
Childhood Sexual Abuse and Psychiatric Disorders in Middle-Aged and Older Adults: Evidence From the 2007 Adult Psychiatric Morbidity Survey PDF
$ 40.00
Childhood Sexual Abuse and Psychiatric Disorders in Middle-Aged and Older Adults: Evidence From the 2007 Adult Psychiatric Morbidity Survey PDF quantity
$ 40.00
×
Alcohol and Prescription Drug Abuse and Borderline Personality Disorder Symptomatology Among Male and Female Perpetrators of Partner Violence PDF
$ 40.00
Alcohol and Prescription Drug Abuse and Borderline Personality Disorder Symptomatology Among Male and Female Perpetrators of Partner Violence PDF quantity
$ 40.00
×
A Double-Blind, Multicenter Study in Primary Care Comparing Paroxetine and Clomipramine in Patients With Depression and Associated Anxiety PDF
$ 40.00
A Double-Blind, Multicenter Study in Primary Care Comparing Paroxetine and Clomipramine in Patients With Depression and Associated Anxiety PDF quantity
$ 40.00
×
Excessive Daytime Sleepiness in Adult Patients With ADHD as Measured by the Maintenance of Wakefulness Test, an Electrophysiologic Measure PDF
$ 40.00
Excessive Daytime Sleepiness in Adult Patients With ADHD as Measured by the Maintenance of Wakefulness Test, an Electrophysiologic Measure PDF quantity
$ 40.00
×
Effectiveness of Brief Cognitive-Behavioral Therapy for Schizophrenia Delivered by Mental Health Nurses: Relapse and Recovery at 24 Months PDF
$ 40.00
Effectiveness of Brief Cognitive-Behavioral Therapy for Schizophrenia Delivered by Mental Health Nurses: Relapse and Recovery at 24 Months PDF quantity
$ 40.00
×
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S -Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder PDF
$ 40.00
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder PDF quantity
$ 40.00
×
Prevalence and Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia in a Geriatric Psychiatry Unit: A Retrospective Analysis PDF
$ 40.00
Prevalence and Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia in a Geriatric Psychiatry Unit: A Retrospective Analysis PDF quantity
$ 40.00
×
Intentional Weight Loss in Overweight and Obese Patients With Severe Mental Illness: 8-Year Experience of a Behavioral Treatment Program PDF
$ 40.00
Intentional Weight Loss in Overweight and Obese Patients With Severe Mental Illness: 8-Year Experience of a Behavioral Treatment Program PDF quantity
$ 40.00
×
Comparison of Treatment-Emergent Extrapyramidal Symptoms in Patients With Bipolar Mania or Schizophrenia During Olanzapine Clinical Trials PDF
$ 40.00
Comparison of Treatment-Emergent Extrapyramidal Symptoms in Patients With Bipolar Mania or Schizophrenia During Olanzapine Clinical Trials PDF quantity
$ 40.00
×
Augmentation of Antidepressants With Atypical Antipsychotic Medications for Treatment-Resistant Major Depressive Disorder: A Meta-Analysis PDF
$ 40.00
Augmentation of Antidepressants With Atypical Antipsychotic Medications for Treatment-Resistant Major Depressive Disorder: A Meta-Analysis PDF quantity
$ 40.00
×
Switching Patients From Daily Citalopram, Paroxetine, or Sertraline to Once-Weekly Fluoxetine in the Maintenance of Response for Depression PDF
$ 40.00
Switching Patients From Daily Citalopram, Paroxetine, or Sertraline to Once-Weekly Fluoxetine in the Maintenance of Response for Depression PDF quantity
$ 40.00
×
High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder PDF
$ 40.00
High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
